EXPLORING THE DIAGNOSTIC SIGNIFICANCE OF GREY LESIONS IN BREAST: A SYSTEMATIC REVIEW AND META-ANALYSIS

doi:10.5281/zenodo.14583222

International Journal of Medical and Pharmaceutical Research

2025, Volume-6, Issue-1 doi: 10.5281/zenodo.14583222

Original Research Article

EXPLORING THE DIAGNOSTIC SIGNIFICANCE OF GREY LESIONS IN BREAST: A SYSTEMATIC REVIEW AND META-ANALYSIS

Dr. Sabiha A Maimoon, Dr.Ibtisam Fatima Salim Shaikh, Dr.Shreyabose, Dr Lata Tapnikar

DOI : 10.5281/zenodo.14583222

Published

Feb. 27, 2025

Abstract

Systemic review and meta-analysis of grey lesions in breast pathology.The current systematic review & meta-analysis adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, making sure that reporting is rigorous and transparent. Our search strategy focused on identifying relevant studies published between May 2020 and May 2021, with an emphasis on English language articles. Medline was systematically queried, and an extensive search of the PubMed Central (PMC) literature was conducted to pinpoint journal articles featuring both FNAC and HPE comparisons. Particularly in a situation where resources are limited, this systematic review and meta-analysis that compares the effectiveness of Fine Needle Aspiration Cytology (FNAC) against Histopathological Examination (HPE) is unique. FNAC exhibits substantial predictability in identifying malignancies within the grey zone of breast lesions, reinforcing its efficacy in resource-limited settings.

Recommended Articles

Volume-6, Issue-1

Downloads

Download PDF pdf

Download XML

Citations

613 Views

151 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.